Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments [2 volumes]
Edited by Michael J. Winkelman, Ph.D.and Thomas B. Roberts, Ph.D
Roberts's faculty webpage:
http://www.cedu.niu.edu/lepf/directory/faculty/roberts.shtml
Winkelman’s website: http://www.public.asu.edu/~atmxw/
Psychedelic substances present in nature have been used by humans across hundreds of years to produce mind-altering changes in thought, mood, and perception - changes we do not experience otherwise except rarely in dreams, religious exaltation, or psychosis. U.S. scientists were studying the practical and therapeutic uses for hallucinogens, including LSD and mescaline, in the 1950s and 1960s supplied by large manufacturers including Sandoz. But the government took steps to ban all human consumption of hallucinogens, and thus the research. By 1970s, all human testing was stopped. Medical concerns were not the issue, the ban was moved by social concerns, not the least of which were created by legendary researcher Timothy Leary, a psychologist who advocated free use of hallucinogens by all who desired. Nationwide, however, a cadre of scholars and researchers has persisted in pushing the federal government to again allow human testing. And the moratorium has been lifted. The FDA has begun approving hallucinogenic research using human subjects. In these groundbreaking volumes, top researchers explain the testing and research underway to use - under the guidance of a trained provider - psychedelic substances for better physical and mental health.
“These books are a comprehensive and scholarly review of the current status of the therapeutic potential of hallucinogens. The contributors represent an outstanding group of scientists, scholars and clinicians, most of whom have had direct experience using and administering these drugs in either therapeutic or religious contexts. The result is an impressive collection. The authors provide scholarly historical reviews of the use of these drugs, as well as detailed instructions and advice for the clinician on how to administer these drugs safely and effectively in a therapeutic context. The authors provide a balanced view and acknowledge the many risks and pitfalls of improper use of these drugs. Likely to be of interest to scientists, clergy, mental health professionals, and anyone interested in the mind. It provides an up to date review of the status of hallucinogens in modern medicine, as well as a historical review of their status in the past. It is highly recommended.” --Harriet de Wit, PhD Professor, Department of Psychiatry The University of Chicago
“Until they were caught up in the cultural revolution of the 1960s, hallucinogens were being seriously examined by top researchers for their potential to alleviate many human ills. The contributors to this volume make a persuasive case that science should now do more to pursue these questions.” -- Professor Jonathan D. Moreno, University of Pennsylvania Center for Bioethics
“Roberts and Winkelman have assembled one of the most impressive and comprehensive collection of writings in the field of psychedelic medicine. The chapters, written by first-rate academic scholars, are rigorous and clear. The topics range from neuroscience to the legal, spiritual, medicinal, and ethical implications of using this novel class of agents. This book is an invaluable resource for educators, clinicians, and policy makers who are interested in rejuvenating the field of psychedelic research.” -- Stephen Ross, M.D. Assistant Clinical Professor, Psychiatry, NYU School of Medicine Director, Division of Alcoholism and Drug Abuse, Bellevue Hospital Associate Director, Addiction Psychiatry Fellowship, NYU School of Medicine
“These volumes present fresh ideas for using psychedelic drugs as therapeutic agents to treat some of the most intractable of psychological ailments. As the authors make clear, the ability of these substances to facilitate direct experiential access to our deepest thoughts, feelings, and spirituality makes them uniquely suited for this purpose. Undoubtedly, their amazing healing potential has yet to be fully realized. Thanks to these forward-thinking educators, researchers, and clinicians, we now have new paths to explore in the cure for old diseases.” -- Nicholas V. Cozzi, Ph.D. Department of Pharmacology University of Wisconsin School of Medicine and Public Health
Psychedelic Medicines: New Evidence for Hallucinogenic Substances as Treatments
Winkelman, Michael, & Roberts, Thomas B. (editors) (2007).
Westport, CT: Praeger/Greenwood Publishers
Volume I: Psychedelic Medicine: Social, Clinical and Legal Perspectives
Preface-Warning. Thomas B. Roberts
Editor’s Overview of Psychedelic Medicines Volume 1. Michael Winkelman
Section I: The Social and Clinical Context
Chapter 1: Therapeutic Bases of Psychedelic Medicines: Psychointegrative Effects. Michael Winkelman
Chapter 2: The Healing Vine: Ayahuasca as Medicine in the 21st Century. Dennis McKenna
Chapter 3: Contemporary Psychedelic Therapy: An Overview. Torsten Passie
Chapter 4: Therapeutic Guidelines: Dangers and Contra-Indications in Therapeutic Applications of Hallucinogens. Ede Frecska
Section II: Medical Applications
Chapter 5: Response of Cluster Headaches to Psilocybin and LSD. Andrew Sewell & John H. Halpern
Chapter 6: Psilocybin Treatment of Obsessive- Compulsive Disorder. F. A. Moreno & P. L. Delgado
Chapter 7: Therapeutic Uses of MDMA. George Greer & Requa Tolbert
Chapter 8: MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder. Michael Mithoefer
Chapter 9: Psychedelic Drugs for the Treatment of Depression. Michael Montagne
Chapter 10: Marijuana and AIDS. Donald Abrams
Chapter 11: The Use of Psilocybin in Patients with Advanced Cancer and Existential Anxiety. C. Grob
Section III: Legal Aspects of the Medical Use
Chapter 12: Psychedelic Medicine and the Law. Richard Boire
Chapter 13: The Legal Bases for Religious Peyote Use. Kevin Feeney
Chapter 14: The Supreme Court’s Psychedelic Case. Alberto Groisman & Marlene de Rios
Chapter 15: Conclusions. Michael Winkelman & Thomas B. Roberts
Volume II: Psychedelic Medicine: Addictions Medicine and Transpersonal Healing
Preface- Lancet Editorial
Chapter 1: Introduction — The Adventure Continues. Thomas B. Roberts
Section I: Treating Substance Abuse
Chapter 2: Hallucinogens in the Treatment of Alcoholism and Other Addictions. J. H. Halpern
Chapter 3: Addiction, Despair, and the Soul: Psychedelic Psychotherapy. R. Yensen & D. Dryer
Chapter 4: The Therapeutic Use of Peyote in the Native American Church. Joseph Calabrese
Chapter 5: Ibogaine and Substance Abuse Rehabilitation. Kenneth R. Alper & Howard Lotsof
Chapter 6: Ketamine Psychedelic Psychotherapy. Evgeny Krupitsky & Eli Kolp
Chapter 7: Ayahuasca Treatment of Cocaine-Paste Addiction. Jacques Mabit
Section II: Guidelines for Psychotherapeutic Applications
Chapter 8: The Ten Lessons of Psychedelic Psychotherapy… Rediscovered. Neal Goldsmith
Chapter 9: Therapeutic Guidelines from Shamanic Traditions. Michael Winkelman
Chapter 10: Common Processes in Psychospiritual Change. Sean House
Chapter 11: Preliminary Remarks on Interpreting Resistance to Psychedelic Insights. Dan Merkur
Section III: Transpersonal Dimension of Healing with Psychedelic Medicines
Chapter 12: Psychedelics in Psychological Health and Growth. Roger Walsh & Charles Grob
Chapter 13: Psilocybin Can Occasion Mystical-type Experiences Having Substantial and Sustained Personal Meaning and Spiritual Significance. R. Griffiths, W. Richards, U. McCann & R. Jesse.
Chapter 14: Remarkable Healing During Psychedelic Psychotherapy. Stanislav Grof
Chapter 15: Transpersonal Healing with Hallucinogens. Roger Marsden & David Lukoff
Chapter 16: Conclusions and Future Recommendations: The Wider Contexts. Thomas B. Roberts
Author biographies
Index
List Price: $200.00 0-275-99023-0/978-0-275-99023-7 Pages: Publication: 6/30/2007
To order, visit www.greenwood.com, call 1-800-225-5800, or use this order form:
ISBN / Title / Price / Qty / Total0-275-99023-0
978-0-275-99023-7 / Psychedelic Medicine [Two Volumes] / $200.00
If paying by check, please add shipping and handling: U.S. residents add 10%; Canada residents, add 12%; $8.00 minimum.
IL, MA, MD, MO, NJ, VT residents add sales tax on subtotal. CO, CT, PA, & SD residents add sales tax on subtotal plus shipping charges. Canada residents add GST tax. Enclose tax-exempt certificate if applicable. / Subtotal
Shipping
Sales Tax
Total
Name:
Address:
City:
State:
Zip:
Telephone:
Email:
Check enclosed made payable to Greenwood Publishing Group
Charge Credit Card: VISA MC AMEX
Credit Card #:
Expiration Date:
Signature (required):
Mail this form to: Greenwood Publishing Group,
P.O. Box 6926, Portsmouth, NH 03802-6926